GB9126761D0 - Antiviral sulphated polysaccharides - Google Patents

Antiviral sulphated polysaccharides

Info

Publication number
GB9126761D0
GB9126761D0 GB919126761A GB9126761A GB9126761D0 GB 9126761 D0 GB9126761 D0 GB 9126761D0 GB 919126761 A GB919126761 A GB 919126761A GB 9126761 A GB9126761 A GB 9126761A GB 9126761 D0 GB9126761 D0 GB 9126761D0
Authority
GB
United Kingdom
Prior art keywords
antiviral
sulphated polysaccharides
sulphated
polysaccharides
antiviral sulphated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB919126761A
Other versions
GB2262531B (en
GB2262531A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Priority to GB9126761A priority Critical patent/GB2262531B/en
Publication of GB9126761D0 publication Critical patent/GB9126761D0/en
Priority to ITMI922851A priority patent/IT1256659B/en
Priority to JP4334561A priority patent/JPH05271306A/en
Priority to DE4242813A priority patent/DE4242813A1/de
Publication of GB2262531A publication Critical patent/GB2262531A/en
Application granted granted Critical
Publication of GB2262531B publication Critical patent/GB2262531B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0039—Agar; Agarose, i.e. D-galactose, 3,6-anhydro-D-galactose, methylated, sulfated, e.g. from the red algae Gelidium and Gracilaria; Agaropectin; Derivatives thereof, e.g. Sepharose, i.e. crosslinked agarose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
GB9126761A 1991-12-17 1991-12-17 Antiviral sulphated polysaccharides Expired - Fee Related GB2262531B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9126761A GB2262531B (en) 1991-12-17 1991-12-17 Antiviral sulphated polysaccharides
ITMI922851A IT1256659B (en) 1991-12-17 1992-12-14 ANTIVIRAL SULPHATED POLYSACCHARIDES
JP4334561A JPH05271306A (en) 1991-12-17 1992-12-15 Antiviral sulphated polysaccharides
DE4242813A DE4242813A1 (en) 1991-12-17 1992-12-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9126761A GB2262531B (en) 1991-12-17 1991-12-17 Antiviral sulphated polysaccharides

Publications (3)

Publication Number Publication Date
GB9126761D0 true GB9126761D0 (en) 1992-02-12
GB2262531A GB2262531A (en) 1993-06-23
GB2262531B GB2262531B (en) 1995-12-06

Family

ID=10706401

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9126761A Expired - Fee Related GB2262531B (en) 1991-12-17 1991-12-17 Antiviral sulphated polysaccharides

Country Status (4)

Country Link
JP (1) JPH05271306A (en)
DE (1) DE4242813A1 (en)
GB (1) GB2262531B (en)
IT (1) IT1256659B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
WO2000043018A1 (en) * 1999-01-20 2000-07-27 Takara Shuzo Co., Ltd. Medicinal compositions
DE10200717A1 (en) * 2002-01-10 2003-07-31 Knoell Hans Forschung Ev Use of polysaccharide derivatives as anti-infective substances
PL225045B1 (en) 2012-05-18 2017-02-28 Univ Jagiellonski Use of chitosan polymer for the treatment and prophylaxis of infections caused by coronaviruses

Also Published As

Publication number Publication date
JPH05271306A (en) 1993-10-19
ITMI922851A0 (en) 1992-12-14
GB2262531B (en) 1995-12-06
GB2262531A (en) 1993-06-23
DE4242813A1 (en) 1993-06-24
IT1256659B (en) 1995-12-12
ITMI922851A1 (en) 1994-06-14

Similar Documents

Publication Publication Date Title
CS114591A3 (en) Antiviral mixtures
GB2262123B (en) Window
HU9303219D0 (en) Deformable bogie-frame
ZA913721B (en) Antiviral agents
EP0453099A3 (en) Weft straightener
ZA901993B (en) Antiviral compositions
GB2254456B (en) Micro-controller unit
ZA936452B (en) Sulphated glycoside
EP0497988A4 (en) Antiviral agent
GB2262531B (en) Antiviral sulphated polysaccharides
GB9101960D0 (en) Window structure
GB9125891D0 (en) Antiviral agent
GB8911158D0 (en) Antiviral pyridazinamines
GB9116030D0 (en) Antiviral compositions
GB2261246B (en) Window
GB9010990D0 (en) Ladder
GB9215176D0 (en) Antiviral combinations
ZA918158B (en) 5beta-and 13beta ivermectin monoglucopyranosides
IL110242A0 (en) Antiviral polysaccharides
GB9125027D0 (en) Polysaccharides
EP0516300A3 (en) Saccharide mercaptals
CS631290A3 (en) Antiviral gel
GB9025421D0 (en) Polysaccharides
GB9122073D0 (en) Antiviral agents
GB9224802D0 (en) Polysaccharides

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19961217